BR112018068493A2 - células-tronco estromais, uso de células-tronco estromais e método de tratamento de uma fístula perianal complexa refratária - Google Patents
células-tronco estromais, uso de células-tronco estromais e método de tratamento de uma fístula perianal complexa refratáriaInfo
- Publication number
- BR112018068493A2 BR112018068493A2 BR112018068493A BR112018068493A BR112018068493A2 BR 112018068493 A2 BR112018068493 A2 BR 112018068493A2 BR 112018068493 A BR112018068493 A BR 112018068493A BR 112018068493 A BR112018068493 A BR 112018068493A BR 112018068493 A2 BR112018068493 A2 BR 112018068493A2
- Authority
- BR
- Brazil
- Prior art keywords
- stem cells
- stromal stem
- treatment
- complex perianal
- perianal fistula
- Prior art date
Links
- 210000000130 stem cell Anatomy 0.000 title abstract 3
- 206010002156 anal fistula Diseases 0.000 title abstract 2
- 208000011231 Crohn disease Diseases 0.000 abstract 1
- 230000000735 allogeneic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0653—Adipocytes; Adipose tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
são providas aqui células-tronco estromais derivadas de tecido adiposo, alogênicas, expandidas para uso no tratamento de fístulas perianais complexas em doença de crohn.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1604304.4 | 2016-03-14 | ||
GBGB1604304.4A GB201604304D0 (en) | 2016-03-14 | 2016-03-14 | Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease |
IB2017158509 | 2017-09-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112018068493A2 true BR112018068493A2 (pt) | 2019-01-22 |
BR112018068493A8 BR112018068493A8 (pt) | 2022-06-28 |
Family
ID=55952284
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112018068493A BR112018068493A8 (pt) | 2016-03-14 | 2017-03-14 | Células-tronco estromais, uso de células-tronco estromais e método de tratamento de uma fístula perianal complexa refratária |
Country Status (27)
Country | Link |
---|---|
US (3) | US10357518B2 (pt) |
EP (2) | EP3219321B1 (pt) |
JP (2) | JP6931656B2 (pt) |
KR (1) | KR102277789B1 (pt) |
CN (2) | CN108883135B (pt) |
AU (1) | AU2017232718B2 (pt) |
BE (1) | BE1024781B1 (pt) |
BR (1) | BR112018068493A8 (pt) |
CA (1) | CA3017694C (pt) |
DE (1) | DE102017002458B4 (pt) |
DK (1) | DK3219321T3 (pt) |
ES (2) | ES2911718T3 (pt) |
FR (1) | FR3048614B1 (pt) |
GB (2) | GB201604304D0 (pt) |
HR (1) | HRP20220539T1 (pt) |
HU (1) | HUE058739T2 (pt) |
IL (2) | IL261730B2 (pt) |
LT (1) | LT3219321T (pt) |
MX (1) | MX2018010699A (pt) |
NL (1) | NL2018512B1 (pt) |
NO (1) | NO345415B1 (pt) |
PL (1) | PL3219321T3 (pt) |
RS (1) | RS63163B1 (pt) |
RU (1) | RU2742308C2 (pt) |
SG (2) | SG10202008992YA (pt) |
SI (1) | SI3219321T1 (pt) |
WO (1) | WO2017158509A1 (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060045872A1 (en) | 2004-08-25 | 2006-03-02 | Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco | Use of adipose tissue-derived stromal stem cells in treating fistula |
GB201604304D0 (en) * | 2016-03-14 | 2016-04-27 | Tigenix S A U | Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease |
WO2018183941A2 (en) | 2017-03-30 | 2018-10-04 | Progenity Inc. | Treatment of a disease of the gastrointestinal tract with live biotherapeutics |
SG11202108114YA (en) * | 2019-02-27 | 2021-08-30 | Tigenix S A U | Improved stem cell populations for allogeneic therapy |
CN111481573A (zh) * | 2020-03-26 | 2020-08-04 | 卡替(上海)生物技术股份有限公司 | 牙髓间充质干细胞在制备克罗恩病治疗药物中的用途 |
JP2023551479A (ja) * | 2020-11-25 | 2023-12-08 | フラッグシップ パイオニアリング, インコーポレイテッド | 脂肪生成細胞組成物及び方法 |
WO2023230524A1 (en) * | 2022-05-25 | 2023-11-30 | Flagship Pioneering Innovations Vi, Llc | Compositions of secretory and/or catalytic cells and methods using the same |
Family Cites Families (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US6010696A (en) | 1990-11-16 | 2000-01-04 | Osiris Therapeutics, Inc. | Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells |
US5486359A (en) | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
US5733542A (en) | 1990-11-16 | 1998-03-31 | Haynesworth; Stephen E. | Enhancing bone marrow engraftment using MSCS |
EP0672033B1 (en) | 1992-12-02 | 1998-03-11 | Shell Internationale Researchmaatschappij B.V. | Azoxycyanobenzene derivatives |
US5578475A (en) | 1993-07-12 | 1996-11-26 | Life Technologies, Inc. | Composition and methods for transfecting eukaryotic cells |
US5472183A (en) | 1994-03-17 | 1995-12-05 | Nisca Corporation | Sheet feeding device with multiple sheet stackers |
US6174333B1 (en) | 1994-06-06 | 2001-01-16 | Osiris Therapeutics, Inc. | Biomatrix for soft tissue regeneration using mesenchymal stem cells |
DE69531638T2 (de) | 1994-06-06 | 2004-06-17 | Osiris Therapeutics, Inc. | Biomatrix für geweberegenaration |
US6051429A (en) | 1995-06-07 | 2000-04-18 | Life Technologies, Inc. | Peptide-enhanced cationic lipid transfections |
ATE285477T1 (de) | 1995-06-07 | 2005-01-15 | Inex Pharmaceutical Corp | Herstellung von lipid-nukleinsäure partikeln duch ein hydrophobische lipid-nukleinsäuree komplexe zwischenprodukt und zur verwendung in der gentransfer |
US5744335A (en) | 1995-09-19 | 1998-04-28 | Mirus Corporation | Process of transfecting a cell with a polynucleotide mixed with an amphipathic compound and a DNA-binding protein |
US6546106B2 (en) | 1996-09-03 | 2003-04-08 | New Transducers Limited | Acoustic device |
US5705308A (en) | 1996-09-30 | 1998-01-06 | Eastman Kodak Company | Infrared-sensitive, negative-working diazonaphthoquinone imaging composition and element |
AU1615599A (en) | 1997-12-02 | 1999-06-16 | Zen Bio, Inc. | Differentiation of adipose stromal cells into osteoblasts and uses thereof |
US6368636B1 (en) | 1998-03-18 | 2002-04-09 | Osiris Therapeutics, Inc. | Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
US9585916B2 (en) | 1999-03-26 | 2017-03-07 | Northern Therapeutics Inc. | Cell based therapy for the pulmonary system |
JP2002510655A (ja) | 1998-04-03 | 2002-04-09 | オシリス セラピューティクス,インコーポレイテッド | 免疫抑制剤としての間葉幹細胞によるt細胞応答を阻害する方法とその利用 |
US6546105B1 (en) | 1998-10-30 | 2003-04-08 | Matsushita Electric Industrial Co., Ltd. | Sound image localization device and sound image localization method |
US6777231B1 (en) | 1999-03-10 | 2004-08-17 | The Regents Of The University Of California | Adipose-derived stem cells and lattices |
KR100870508B1 (ko) | 1999-03-10 | 2008-11-25 | 유니버시티 오브 피츠버그 오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 | 지방 유래 간세포 및 격자 |
US20030082152A1 (en) | 1999-03-10 | 2003-05-01 | Hedrick Marc H. | Adipose-derived stem cells and lattices |
US20050153442A1 (en) | 1999-03-10 | 2005-07-14 | Adam Katz | Adipose-derived stem cells and lattices |
US7670628B2 (en) | 1999-07-07 | 2010-03-02 | Angioblast Systems, Inc. | Mesenchymal precursor cell |
US6555374B1 (en) | 1999-08-19 | 2003-04-29 | Artecel Sciences, Inc. | Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof |
WO2002067867A2 (en) | 2001-02-23 | 2002-09-06 | The University Of Pittsburgh | Rapid preparation of stem cell matrices for use in tissue and organ treatment and repair |
US20030054331A1 (en) | 2001-09-14 | 2003-03-20 | Stemsource, Inc. | Preservation of non embryonic cells from non hematopoietic tissues |
EP1451300A4 (en) | 2001-11-09 | 2007-01-10 | Artecel Sciences Inc | METHODS AND COMPOSITIONS IN WHICH STROMAL CELLS ARE USED TO SUPPORT EMBRYONIC AND ADULT STEM CELLS |
JP2005533480A (ja) * | 2001-11-09 | 2005-11-10 | アーテセル・サイエンシズ・インコーポレーテツド | 脂肪組織由来間質細胞の膵内分泌分化およびその使用 |
US7771716B2 (en) | 2001-12-07 | 2010-08-10 | Cytori Therapeutics, Inc. | Methods of using regenerative cells in the treatment of musculoskeletal disorders |
AU2003225791A1 (en) | 2002-03-15 | 2003-09-29 | Department Of Veterans Affairs, Rehabilitation R And D Service | Methods and compositions for directing cells to target organs |
CA2489212C (en) | 2002-06-14 | 2012-08-14 | Cartela Ab | Marker for stem cells and its use |
US20040101959A1 (en) | 2002-11-21 | 2004-05-27 | Olga Marko | Treatment of tissue with undifferentiated mesenchymal cells |
CA2784829C (en) | 2003-04-01 | 2015-10-06 | United States Of America Department Of Veteran's Affairs | Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction |
ES2265199B1 (es) | 2003-06-12 | 2008-02-01 | Cellerix, S.L. | Celulas madre adultas multipotentes procedentes de condrocitos desdiferenciados y sus aplicaciones. |
JP4950660B2 (ja) | 2003-06-27 | 2012-06-13 | エチコン、インコーポレイテッド | 分娩後由来細胞を使用する眼組織の修復および再生 |
US7645229B2 (en) | 2003-09-26 | 2010-01-12 | Armstrong David N | Instrument and method for endoscopic visualization and treatment of anorectal fistula |
JP4749331B2 (ja) | 2003-10-07 | 2011-08-17 | 株式会社バイオマスター | 脂肪由来前駆細胞の細胞分化 |
US9631176B2 (en) | 2003-11-04 | 2017-04-25 | Biomaster, Inc. | Method for preparing stem cells from fat tissue |
US20080095749A1 (en) | 2004-03-22 | 2008-04-24 | Sudeepta Aggarwal | Mesenchymal stem cells and uses therefor |
EP2298862B1 (en) | 2004-03-22 | 2017-08-30 | Mesoblast International Sàrl | Mesenchymal stem cells and uses therefor |
RU2252252C1 (ru) | 2004-04-09 | 2005-05-20 | Тепляшин Александр Сергеевич | Способ выделения мезенхимальных стволовых клеток |
ES2264862B8 (es) | 2004-08-25 | 2017-01-20 | Cellerix, S.L. | Biomaterial para sutura. |
ES2313805B1 (es) * | 2004-10-04 | 2009-12-23 | Cellerix, S.L. | Identificacion y aislamiento de celulas multipotentes de tejido mesenquimal no osteocondral. |
US20060045872A1 (en) * | 2004-08-25 | 2006-03-02 | Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco | Use of adipose tissue-derived stromal stem cells in treating fistula |
WO2006029347A2 (en) | 2004-09-03 | 2006-03-16 | University Of Maryland, Baltimore | Integrin cd18 is a novel stromal stem cell marker and functions to promote osteogenesis |
US20060286089A1 (en) | 2005-04-08 | 2006-12-21 | Xcyte Therapies, Inc. | Compositions and methods for the treatment of burns and sepsis |
LT1926813T (lt) | 2005-09-23 | 2016-11-10 | Tigenix, S.A.U. | Ląstelių populiacijos, pasižyminčios imunoreguliaciniu aktyvumu, izoliavimo būdas ir panaudojimas |
EP1795588A1 (en) | 2005-12-07 | 2007-06-13 | Cellerix, S.L. | Use of adipose tissue derived mesenchymal stem cells for the treatment of graft versus host disease |
US20120269774A1 (en) | 2006-09-21 | 2012-10-25 | Medistem Laboratories, Inc | Allogeneic stem cell transplants in non-conditioned recipients |
US20110262402A1 (en) | 2007-09-07 | 2011-10-27 | Masahiko Kuroda | Therapeutic and prophylactic agents for arthritis |
SI2200622T2 (sl) | 2007-09-19 | 2015-09-30 | Pluristem Ltd. | Adherentne celice iz adipoznih ali placentnih tkiv in njihova uporaba pri terapiji |
JP5539886B2 (ja) | 2007-10-17 | 2014-07-02 | ティクセル | Tr1細胞、間葉系幹細胞およびその使用 |
GB0814249D0 (en) | 2008-08-04 | 2008-09-10 | Cellerix Sa | Uses of mesenchymal stem cells |
ES2345867B1 (es) * | 2009-04-03 | 2011-07-28 | Fundacion Instituto Mediterraneo Para La Biotecnologia Y La Investigacion Sanitaria (Imabis) | Celulas madre multipotentes derivadas de estroma de mesenterio. |
CN102421444B (zh) * | 2009-04-28 | 2016-08-03 | 安特罗根有限公司 | 用于治疗瘘的自体和异体脂肪来源的基质干细胞组合物 |
US8679834B2 (en) | 2009-07-09 | 2014-03-25 | TiGenix S.A.U | Methods and compositions for use in cellular therapies |
WO2012078536A2 (en) * | 2010-12-06 | 2012-06-14 | Quark Pharmaceuticals, Inc. | Double stranded oligonucleotide compounds comprising positional modifications |
ES2479544T1 (es) | 2011-01-12 | 2014-08-20 | Tigenix, S.A.U. | Células madre mesenquimales derivadas de tejido adiposo para administración intralinfática en enfermedades autoimmunes e inflamatorias |
EP2683813A1 (en) | 2011-03-11 | 2014-01-15 | TiGenix, S.A.U. | Cell populations having immunoregulatory activity, method for isolation and uses |
US20140134140A1 (en) | 2012-11-09 | 2014-05-15 | Case Western Reserve University | Mesenchymal stem cell compositions for the treatment of microbial infections |
EP2972368B1 (en) * | 2013-03-15 | 2019-07-24 | TiGenix, S.A.U. | Lymphocyte biomarkers for determining the clinical response to cell therapy |
JP6412933B2 (ja) | 2013-06-25 | 2018-10-24 | ティジェニクス エス.エー.ユー. | 免疫調節活性を有する細胞集団、その調製方法および使用 |
KR102213527B1 (ko) * | 2014-06-30 | 2021-02-09 | 타이제닉스, 에스.에이.유. | 패혈증 치료용 중간엽 기질세포 |
CN108138142A (zh) * | 2015-09-24 | 2018-06-08 | 塞莱克特生物疗法有限公司 | 繁殖用在移植中的间质干细胞(msc)的方法 |
GB201604304D0 (en) * | 2016-03-14 | 2016-04-27 | Tigenix S A U | Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease |
-
2016
- 2016-03-14 GB GBGB1604304.4A patent/GB201604304D0/en not_active Ceased
-
2017
- 2017-03-14 RU RU2018131519A patent/RU2742308C2/ru active
- 2017-03-14 BE BE2017/5156A patent/BE1024781B1/de active IP Right Grant
- 2017-03-14 WO PCT/IB2017/051468 patent/WO2017158509A1/en active Application Filing
- 2017-03-14 MX MX2018010699A patent/MX2018010699A/es unknown
- 2017-03-14 EP EP17160932.4A patent/EP3219321B1/en active Active
- 2017-03-14 SG SG10202008992YA patent/SG10202008992YA/en unknown
- 2017-03-14 JP JP2018548356A patent/JP6931656B2/ja active Active
- 2017-03-14 HR HRP20220539TT patent/HRP20220539T1/hr unknown
- 2017-03-14 BR BR112018068493A patent/BR112018068493A8/pt active IP Right Grant
- 2017-03-14 US US15/458,509 patent/US10357518B2/en active Active
- 2017-03-14 IL IL261730A patent/IL261730B2/en unknown
- 2017-03-14 AU AU2017232718A patent/AU2017232718B2/en active Active
- 2017-03-14 CN CN201780017154.3A patent/CN108883135B/zh active Active
- 2017-03-14 CA CA3017694A patent/CA3017694C/en active Active
- 2017-03-14 KR KR1020187029414A patent/KR102277789B1/ko active IP Right Grant
- 2017-03-14 PL PL17160932T patent/PL3219321T3/pl unknown
- 2017-03-14 ES ES17160932T patent/ES2911718T3/es active Active
- 2017-03-14 DE DE102017002458.8A patent/DE102017002458B4/de active Active
- 2017-03-14 ES ES201700204A patent/ES2681774B1/es active Active
- 2017-03-14 CN CN202211257331.4A patent/CN115569151A/zh active Pending
- 2017-03-14 LT LTEP17160932.4T patent/LT3219321T/lt unknown
- 2017-03-14 DK DK17160932.4T patent/DK3219321T3/da active
- 2017-03-14 GB GB1704065.0A patent/GB2548490B/en active Active
- 2017-03-14 FR FR1752073A patent/FR3048614B1/fr active Active
- 2017-03-14 IL IL298107A patent/IL298107B2/en unknown
- 2017-03-14 SI SI201731122T patent/SI3219321T1/sl unknown
- 2017-03-14 NL NL2018512A patent/NL2018512B1/nl active
- 2017-03-14 RS RS20220355A patent/RS63163B1/sr unknown
- 2017-03-14 NO NO20170376A patent/NO345415B1/en unknown
- 2017-03-14 HU HUE17160932A patent/HUE058739T2/hu unknown
- 2017-03-14 SG SG11201807404XA patent/SG11201807404XA/en unknown
- 2017-03-14 EP EP22163484.3A patent/EP4074322A1/en active Pending
-
2019
- 2019-06-25 US US16/452,321 patent/US11273182B2/en active Active
-
2021
- 2021-05-17 JP JP2021083406A patent/JP2021119789A/ja active Pending
-
2022
- 2022-02-14 US US17/671,479 patent/US20220249574A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112018068493A2 (pt) | células-tronco estromais, uso de células-tronco estromais e método de tratamento de uma fístula perianal complexa refratária | |
MX2020004830A (es) | Medios y metodo para preparar vectores virales y usos de los mismos. | |
MX2020005634A (es) | Composiciones y metodos para mejorar los linfocitos infiltrantes de tumor para terapia celular adoptiva. | |
SG10201803042PA (en) | Anti-tim-3 antibodies | |
BR112016022814A8 (pt) | composição farmacêutica e seu método de preparação, ácido nucleico, e dispositivo médico ou kit médico | |
IL289099A (en) | Methods for storage of whole blood, and corresponding preparations | |
MX2019007021A (es) | Anticuerpos il-11ra. | |
ZA201708607B (en) | Agents, uses and methods for the treatment of synucleinopathy | |
IL266596A (en) | Causes, uses and methods of treating synovialitis | |
SG11201610857TA (en) | Cultured mammalian limbal stem cells, methods for generating the same, and uses thereof | |
MX2020004043A (es) | Composiciones y métodos para la edición génica de hemofilia a. | |
DK3728121T3 (da) | Lanthaniddoterede, lagdelte dobbelthydroxider og fremgangsmåde til fremstilling af samme | |
SG10201810150UA (en) | Compositions and methods for enhanced gene expression in cone cells | |
BR112016016916A2 (pt) | método de tratamento de angiodema hereditário (hae) | |
GB2548059A (en) | Induced hepatocytes and uses thereof | |
TW201612308A (en) | Collector architecture layout design | |
GB201700621D0 (en) | Method,device and kit for the aseptic isolation,enrichment and stabilsation of cells from mammalian solid tissue | |
MX2019008872A (es) | Prevencion y tratamiento de da?o o enfermedad osea y cartilago. | |
EP3138399C0 (en) | COMPOSITION FOR ORGAN, TISSUE OR CELL TRANSPLANTATION, KIT AND TRANSPLANTATION METHOD | |
MY193650A (en) | Extracellular matrix compositions | |
MX2017010883A (es) | Composicion para el tratamiento de la infertilidad. | |
WO2016007540A3 (en) | Compositions and methods for treating dengue virus infection | |
ZA202000574B (en) | Mesenchymal stem cells as vaccine adjuvants and methods for using the same | |
MA40592A (fr) | Compositions et méthodes pour le traitement d'une maladie inflammatoire de l'intestin à l'aide d'une polythérapie à base d'inhibiteurs à petites molécules de récepteur 9 de chimiokine c-c (ccr9) et d'anticorps bloquants anti-intégrine alpha4beta7 | |
MX2018005987A (es) | Compuestos heterociclicos para el tratamiento de enfermedades. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
B25A | Requested transfer of rights approved |
Owner name: TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) |
|
B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 14/03/2017, OBSERVADAS AS CONDICOES LEGAIS |